Anticontractile activity of perivascular fat in obese mice and the effect of long-term treatment with melatonin

Journal of Hypertension

Volumn 32, Issue 6, 2014, Pages 1264-1274

  Agabiti Rosei, Claudia ^a   De Ciuceis, Carolina ^a   Rossini, Claudia ^a   Porteri, Enzo ^a   Rodella, Luigi F ^b   Withers, Sarah B ^c   Heagerty, Anthony M ^c   Favero, Gaia ^b   Agabiti Rosei, Enrico ^a   Rizzoni, Damiano ^a   Rezzani, Rita ^b  

^a Department of Clinical and Experimental Sciences ^*  (France)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

hypoxia; iberiotoxin; melatonin; microcirculation; obese mice; obesity; small arteries

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; CHLORDANE; ENDOTHELIN 1; GELATINASE A; GELATINASE B; GLUCOSE; IBERIOTOXIN; INTERLEUKIN 6; MELATONIN; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; PEPTIDE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY RESISTANCE; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXPERIMENTAL OBESITY; GLUCOSE BLOOD LEVEL; HYPOXEMIA; IN VITRO STUDY; INTRAABDOMINAL FAT; LONG TERM CARE; MALE; MESENTERIC ARTERY; MOUSE; MYOGRAPHY; NONHUMAN; OXYGEN TENSION; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANOXIA; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; INFLAMMATION; METABOLISM; MOUSE MUTANT; OBESITY; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; VASOCONSTRICTION;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANOXIA; ANTIOXIDANTS; BODY WEIGHT; INFLAMMATION; MALE; MELATONIN; MESENTERIC ARTERIES; MICE; MICE, OBESE; MICROSCOPY, FLUORESCENCE; NOREPINEPHRINE; OBESITY; OXIDATIVE STRESS; PEPTIDES; RECEPTORS, ADIPONECTIN; VASOCONSTRICTION;

EID: 84900453809     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000178     Document Type: Article

References (47)

1. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009; 119:1661-1670.
2. Ahima RS. Adipose tissue as an endocrine organ. Obesity 2006; 14 (Suppl 5):242S-249S.
3. Guerre-Millo M. Adipose tissue hormones. J Endocrinol Invest 2002; 25:855-861.
4. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J 2002; 16:1057-1063.
5. Dubrovska G, Verlohren S, Luft FC, Gollasch M. Mechanisms of ADRF release from rat aortic adventitial adipose tissue. Am J Physiol Heart Circ Physiol 2003; 286:H1107-H1113.
6. Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, et al. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004; 44:271-276.
7. Gao YJ, Lu C, Su LY, Sharma AM, Lee RMKW. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol 2007; 151:323-331.
8. Withers SB, Agabiti Rosei C, Livingstone DM, Little MC, Aslam R, Malik RA, et al. Studies in CD11b-DTR macrophage deficient mice prove that macrophage activation is responsible for the loss of anticontractile function in inflamed perivascular adipose tissue. Arterioscler Thromb Vascular Biol 2011; 31:908-913.
9. Wang B, Wood IS, Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 2007; 455:479-492.
10. Pagé EL, Robitaille GA, Pouysségur J, Richard DE. Induction of hypoxia-inducible factor-1a by transcriptional and translational mechanisms. J Biol Chem 2002; 277:48403-48409.
11. Aghamohammadzadeh R, Heagerty AM. Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue. Ann Med 2012; 44 (Suppl 1):S74-S84.
12. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999; 17:555-560.
13. Cassis LA, Police SB, Yiannikouris F, Thatcher SE. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 2008; 10:93-98.
14. Aghamohammadzadeh R, Withers S, Lynch F, Greenstein A, Malik R, Heagerty A. Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target. Br J Pharmacol 2012; 165:670-682.
15. Lynch FM, Austin C, Heagerty AM, Izzard AS. Adenosine-and hypoxia-induced dilation of human coronary resistance arteries: evidence against the involvement of K(ATP) channels. Br J Pharmacol 2006; 147:455-458.
16. Lynch FM, Withers SB, Yao Z, Werner ME, Edwards G, Weston AH, et al. Perivascular adipose tissue-derived adiponectin activates BK(Ca) channels to induce anticontractile responses. Am J Physiol Heart Circ Physiol 2013; 304:H786-H795.
17. Weston AH, Egner I, Dong Y, Porter EL, Heagerty AM, Edwards G. Stimulated release of a hyperpolarizing factor (ADHF) from mesenteric artery perivascular adipose tissue: involvement of myocyte BKCa channels and adiponectin. Br J Pharmacol 2013; 169:1500-1509.
18. Rezzani R, Porteri E, De Ciuceis C, Bonomini F, Rodella LF, Paiardi S, et al. Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats. Hypertension 2010; 55:1373-1380.
19. Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res 2008; 44:26-40.
20. Ríos-Lugo MJ, Cano P, Jiménez-Ortega V, Fernández-Mateos MP, Scacchi PA, Cardinali DP, Esquifino AI. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. J Pineal Res 2010; 49:342-348.
21. Kitagawa A, Ohta Y, Ohashi K. Melatonin improves metabolic syndrome induced by high fructose intake in rats. J Pineal Res 2012; 52:403-413.
22. Tan DX, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev 2011; 12:167-188.
23. Guerre-Millo M. Regulation of ob gene and overexpression in obesity. Biomed Pharmacother 1997; 51:318-323.
24. Lindström P the physiology of obese-hyperglycemic mice [ob/ob mice]. Sci World J 2007; 7:666-685.
25. Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007; 293:E1118-E1128.
26. Favero G, Lonati C, Giugno L, Castrezzati S, Rodella LF, Rezzani R. Obesity-related dysfunction of the aorta and prevention by melatonin treatment in ob/ob mice. Acta Histochem 2013; 115:783-788.
27. Sartori C, Dessen P, Mathieu C, Monney A, Bloch J, Nicod P, et al. Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. Endocrinology 2009; 150:5311-5317.
28. Rodella LF, Favero G, Rossini C, Foglio E, Bonomini F, Reiter RJ, et al. Aging and vascular dysfunction: beneficial melatonin effects. Age (Dordr) 2013; 35:103-115.
29. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61: 181-186.
30. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43:854-864.
31. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with not insulin dependent diabetes mellitus. Circulation 2001; 103:1238-1244.
32. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28:785-790.
33. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41:19-26.
34. Giangiacomo KM, Sugg EE, Garcia-Calvo M, Leonard RJ, McManus OB, Kaczorowski GJ, et al. Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels. Biochemistry 1993; 32: 2363-2370.
35. Bonnefont-Rousselot D, Collin F, Jore D, Gardès-Albert M. Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. J Pineal Res 2011; 50:328-335.
36. Radogna F, Diederich M, Ghibelli L. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 2010; 80: 1844-1852.
37. Koziróg M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res 2011; 50:261-266.
38. Prunet-Marcassus B, Desbazeille M, Bros A, Louche K, Delagrange P, Renard P, et al. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology 2003; 144: 5347-5352.
39. Kang MK, Li J, Kim JL, Gong JH, Kwak SN, Park JH, et al. Purple corn anthocyanins inhibit diabetes-associated glomerular monocyte activation and macrophage infiltration. Am J Physiol Renal Physiol 2012; 303:F1060-F1069.
40. Haffner SM. Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med 2007; 120 (9 Suppl 1):S10-S16; discussion S16-S17.
41. Grassi G, Seravalle G, Scopelliti F, Dell'Oro R, Fattori L, Quarti-Trevano F, et al. Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity. Obesity (Silver Spring) 2010; 18:92-98.
42. De Ciuceis C, Porteri E, Rizzoni D, Corbellini C, La Boria E, Boari GE, et al. Effects of weight loss on structural and functional alterations of subcutaneous small arteries in obese patients. Hypertension 2011; 58:29-36.
43. Aghamohammadzadeh R, Greenstein AS, Yadav R, Jeziorska M, Hama S, Soltani F, et al. Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and the restoration of normal anticontractile activity despite persistent obesity. J Am Coll Cardiol 2013; 62:128-135.
44. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444:840-846.
45. Lolmède K, Durand de Saint Front V, Galitzky J, Lafontan M, Bouloumié A. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord 2003; 27:1187-11895.
46. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92:347-355.
47. Sonoyama K, Greenstein A, Price A, Khavandi K, Heagerty AM. Vascular remodeling implications for small artery function and target organ damage ther Advan Cardiovasc Dis 2007; 1:129-137.